McNeill, Daniel R <br/><br/>
Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.  [electronic resource] 

 -  Molecular cancer research : MCR  Jun 2009 
 - 897-906 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-08-0519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>CHO Cells<br/>Cell Cycle--drug effects<br/>Cell Survival--drug effects<br/>Cricetinae<br/>Cricetulus<br/>DNA Repair<br/>DNA-(Apurinic or Apyrimidinic Site) Lyase--biosynthesis<br/>Fluorouracil--pharmacology<br/>G1 Phase--drug effects<br/>Humans<br/>Mutation<br/>Neoplasms--drug therapy